Markets:

Overview

News

Currencies

International

Treasuries

Precigen, Inc. - Common Stock (NQ:PGEN)

3.890 +0.790 (+25.48%)

Official Closing Price Updated: 4:15 PM EDT, Mar 26, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Precigen, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

This Salesforce Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Friday ↗

August 15, 2025

Via Benzinga

Gapping stocks in Friday's session ↗

August 15, 2025

The session on Friday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session.

Via Chartmill

Evolv Technologies, Precigen, Hesai Group And Other Big Stocks Moving Higher On Friday ↗

August 15, 2025

Via Benzinga

Why Is Precigen Stock Surging On Friday? ↗

August 15, 2025

Precigen's Papzimeos wins FDA approval as the first therapy for adult recurrent respiratory papillomatosis, showing durable results in clinical trials.

Via Benzinga

Assessing Precigen: Insights From 5 Financial Analysts ↗

August 15, 2024

Via Benzinga

6 Analysts Assess Precigen: What You Need To Know ↗

June 03, 2024

Via Benzinga

Why KULR Technology Shares Are Trading Higher By Around 19%; Here Are 20 Stocks Moving Premarket ↗

August 15, 2025

Via Benzinga

What's going on in today's pre-market session ↗

August 15, 2025

Let's have a look at what is happening on the US markets before the opening bell on Friday. Below you can find the top gainers and losers in today's pre-market session.

Via Chartmill

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

August 15, 2025

Via Benzinga

Precigen Stock Shot Through The Roof On Friday Morning – Here’s Why ↗

August 15, 2025

The company stated that Papzimeos is now the first and only FDA-approved therapy for the treatment of adults with recurrent respiratory papillomatosis.

Via Stocktwits

Which stocks are moving before the opening bell on Tuesday? ↗

July 22, 2025

The US market is yet to commence its session on Tuesday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.

Via Chartmill

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

July 22, 2025

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

July 16, 2025

Via Benzinga

Verona Pharma, Rhythm Pharmaceuticals, AES And Other Big Stocks Moving Higher On Wednesday ↗

July 09, 2025

Via Benzinga

Hut 8, Greenbrier And Other Big Stocks Moving Higher On Tuesday ↗

July 02, 2025

Via Benzinga

Scholastic Posts Strong Earnings, Joins Ouster, Torrid Holdings, Adaptive Biotechnologies And Other Big Stocks Moving Higher On Friday ↗

March 21, 2025

Via Benzinga

Expert Outlook: Precigen Through The Eyes Of 4 Analysts ↗

March 20, 2025

Via Benzinga

Earnings Scheduled For March 19, 2025 ↗

March 19, 2025

Via Benzinga

Knight-Swift Transportation Posts Upbeat Earnings, Joins TAL Education, LSI Industries, GE Aerospace And Other Big Stocks Moving Higher On Thursday ↗

January 23, 2025

Via Benzinga

Dow Pulls Back From Triple-Digit Gain As New Year Kicks Off ↗

January 02, 2025

Stocks are struggling for direction in the first trading session of the year.

Via Talk Markets

Topics Stocks Stocks / Equities

Precigen Soars: Biologics License Application Submission For PRGN-2012 Targets First FDA-Approved Recurrent Respiratory Papillomatosis Treatment ↗

December 30, 2024

Precigen submits BLA for PRGN-2012 gene therapy targeting RRP, a rare and life-threatening condition with no cure.

Via Benzinga

Titan Machinery Reports Weak Preliminary Results, Joins Precigen, Gogoro And Other Big Stocks Moving Lower In Thursday Pre-Market Session ↗

August 15, 2024

Via Benzinga

Why Lumentum Shares Are Trading Higher By Around 16%; Here Are 20 Stocks Moving Premarket ↗

August 15, 2024

Via Benzinga

PGEN Stock Earnings: Precigen Misses EPS, Misses Revenue for Q2 2024 ↗

August 14, 2024

PGEN stock results show that Precigen missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.

Via InvestorPlace

More Than $20M Bet On Precigen? Check Out These 3 Stocks Under $5 Insiders Are Aggressively Buying ↗

August 14, 2024

Via Benzinga

Why Digital Turbine Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket ↗

August 08, 2024

Via Benzinga

PGEN Stock Earnings: Precigen Misses EPS, Misses Revenue for Q1 2024 ↗

May 14, 2024

PGEN stock results show that Precigen missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.

Via InvestorPlace

PGEN Stock Earnings: Precigen Misses EPS, Misses Revenue for Q4 2023 ↗

March 19, 2024

PGEN stock results show that Precigen missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023.

Via InvestorPlace

Why Science Applications International Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

June 03, 2024

Via Benzinga

Why FactSet Research Shares Are Trading Lower By Around 5%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

March 21, 2024

Shares of FactSet Research Systems Inc. (NYSE: FDS) fell sharply during Thursday’s session after the company reported worse-than-expected second-quarter revenue and issued FY24 guidance.

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.